By Abdulkarim Ibrahim

The National Agency for Food Drugs Administration and Control (NAFDAC) has warned the public about counterfeit Artemether/Lumefantrine tablets, specifically the brand Aflotin 20/120, circulating in Nigeria.

NAFDAC disclosed on Twitter that the counterfeit Aflotin 20/120 tablets were identified and reported to them by the authentic manufacturer, Ajanta Pharma Limited of Mumbai, India.

NAFDAC reported that Ajanta Pharma had originally produced a legitimate batch (PA2128L) of Combisunate 20/120 tablets in December 2018, with an expiration date of November 2020.

However, counterfeiters have now replicated this product and are selling it as Aflotin 20/120 tablets, altering the packaging from 30 x 24 tablets to 1 x 18 tablets.

It added that the overprinted matter did not match Ajanta’s overprinting style.

The agency said the company had confirmed that the Aflotin 20/120mg with Batch No: PA2128L available in the Nigerian market was a counterfeit, as determined by the investigation carried out and observations made on the product.

“The genuine Aflotin 20/120 tablet is a combination of Artemether/Lumefantrine (20mg/120mg) and is primarily used for the treatment of uncomplicated malaria caused by the Plasmodium falciparum parasite,” it said.

NAFDAC warned that counterfeit medicines pose serious health risks because they don’t meet regulatory standards, meaning their safety, quality, and effectiveness are not guaranteed.

“The use of counterfeit medicines often fail to treat diseases or conditions effectively, leading to serious health consequences, including death,” NAFDAC said.

NAFDAC has alerted its zonal directors and state coordinators to conduct surveillance and remove any counterfeit products from the market.

The agency also urges distributors, retailers, healthcare professionals, and caregivers to be cautious and only purchase medical products from authorized and licensed suppliers to prevent the spread of counterfeit goods.

Share.
Leave A Reply

Join Us On WhatsApp
Exit mobile version